New anticoagulants
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (8) , 1843-1853
- https://doi.org/10.1111/j.1538-7836.2005.01374.x
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Ximelagatran: Oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillationJournal of the American College of Cardiology, 2005
- Minor Transplacental Passage of Fondaparinux in VivoNew England Journal of Medicine, 2004
- Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee ReplacementNew England Journal of Medicine, 2003
- Ximelagatran versus warfarin forstroke prevention in patientswith nonvalvular atrial fibrillation: SPORTIF ii: a dose-guiding, tolerability, and safety studyJournal of the American College of Cardiology, 2003
- Ximelagatran, an Oral Direct Thrombin Inhibitor, Has a Low Potential for Cytochrome P450-Mediated Drug-Drug InteractionsClinical Pharmacokinetics, 2003
- Influence of Severe Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Ximelagatran and Subcutaneous MelagatranClinical Pharmacokinetics, 2003
- Influence of Age on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin InhibitorClinical Pharmacokinetics, 2003
- An Economic Evaluation of Activated Protein C Treatment for Severe SepsisNew England Journal of Medicine, 2002
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Comparative safety profiles of hirulog and heparin in patients undergoing coronary angioplastyAmerican Heart Journal, 1995